These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 34307852)
21. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism. He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329 [TBL] [Abstract][Full Text] [Related]
22. 2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism. Kahaly GJ; Bartalena L; Hegedüs L; Leenhardt L; Poppe K; Pearce SH Eur Thyroid J; 2018 Aug; 7(4):167-186. PubMed ID: 30283735 [TBL] [Abstract][Full Text] [Related]
23. A SURVEY OF CLINICAL PRACTICE PATTERNS IN MANAGEMENT OF GRAVES DISEASE IN THE MIDDLE EAST AND NORTH AFRICA. Beshyah SA; Khalil AB; Sherif IH; Benbarka MM; Raza SA; Hussein W; Alzahrani AS; Chadli A Endocr Pract; 2017 Mar; 23(3):299-308. PubMed ID: 27967219 [TBL] [Abstract][Full Text] [Related]
24. Acute Kidney Injury Following Methimazole Initiation: A Case Report. Shell A; Sullivan JW J Pharm Pract; 2020 Feb; 33(1):99-101. PubMed ID: 30111225 [TBL] [Abstract][Full Text] [Related]
25. Thyroid function in wholly breast-feeding infants whose mothers take high doses of propylthiouracil. Momotani N; Yamashita R; Makino F; Noh JY; Ishikawa N; Ito K Clin Endocrinol (Oxf); 2000 Aug; 53(2):177-81. PubMed ID: 10931098 [TBL] [Abstract][Full Text] [Related]
26. Practical treatment with minimum maintenance dose of anti-thyroid drugs for prediction of remission in Graves' disease. Kashiwai T; Hidaka Y; Takano T; Tatsumi KI; Izumi Y; Shimaoka Y; Tada H; Takeoka K; Amino N Endocr J; 2003 Feb; 50(1):45-9. PubMed ID: 12733708 [TBL] [Abstract][Full Text] [Related]
27. Graves' disease in a mediastinal mass presenting after total thyroidectomy for nontoxic multinodular goiter: a case report. Cunha FM; Rodrigues E; Oliveira J; Saavedra A; Vinhas LS; Carvalho D J Med Case Rep; 2016 Mar; 10():70. PubMed ID: 27029843 [TBL] [Abstract][Full Text] [Related]
28. Propylthiouracil hepatitis: report of a case and extensive review of the literature. Memi E; Karras S; Tzotzas T; Krassas GE J Pediatr Endocrinol Metab; 2012; 25(3-4):331-43. PubMed ID: 22768665 [TBL] [Abstract][Full Text] [Related]
29. Radioiodine Therapy-Induced Conversion of Toxic Adenoma to Graves' Disease. Rehman A; Obici S; Yaqub A Cureus; 2020 Jun; 12(6):e8683. PubMed ID: 32699683 [TBL] [Abstract][Full Text] [Related]
30. Short-term hyperthyroidism followed by transient pituitary hypothyroidism in a very low birth weight infant born to a mother with uncontrolled Graves' disease. Higuchi R; Kumagai T; Kobayashi M; Minami T; Koyama H; Ishii Y Pediatrics; 2001 Apr; 107(4):E57. PubMed ID: 11335778 [TBL] [Abstract][Full Text] [Related]
31. Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism. Andrade VA; Gross JL; Maia AL J Clin Endocrinol Metab; 1999 Nov; 84(11):4012-6. PubMed ID: 10566642 [TBL] [Abstract][Full Text] [Related]
33. A case of thyroid storm complicated by acute hepatitis due to propylthiouracil treatment. Tufton N; Hashim N; Sze C; Waterhouse M Endocrinol Diabetes Metab Case Rep; 2015; 2015():150052. PubMed ID: 26279851 [TBL] [Abstract][Full Text] [Related]
34. Hypothyroidism during antithyroid drug treatment with methimazole is a favorable prognostic indicator in patients with Graves' disease. Choo YK; Yoo WS; Kim DW; Chung HK Thyroid; 2010 Sep; 20(9):949-54. PubMed ID: 20629556 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of single daily dosage of methimazole vs. propylthiouracil in the induction of euthyroidism. Homsanit M; Sriussadaporn S; Vannasaeng S; Peerapatdit T; Nitiyanant W; Vichayanrat A Clin Endocrinol (Oxf); 2001 Mar; 54(3):385-90. PubMed ID: 11298092 [TBL] [Abstract][Full Text] [Related]
36. Unusual Endocrinopathies in 18q Deletion Syndrome: Pseudoparathyroidism and Hyper-/Hypo-Thyroidism. Kaulfers AMD; Lim WY; Bhowmick SK AACE Clin Case Rep; 2021; 7(3):192-194. PubMed ID: 34095486 [TBL] [Abstract][Full Text] [Related]
37. Inhibitory effects of methimazole and propylthiouracil on iodotyrosine deiodinase 1 in thyrocytes. Yoshihara A; Luo Y; Ishido Y; Usukura K; Oda K; Sue M; Kawashima A; Hiroi N; Suzuki K Endocr J; 2019 Apr; 66(4):349-357. PubMed ID: 30814441 [TBL] [Abstract][Full Text] [Related]
38. Clinical features of primary hyperthyroidism caused by Graves' disease admixed with resistance to thyroid hormone (P453T). Sato H Endocr J; 2010; 57(8):687-92. PubMed ID: 20574139 [TBL] [Abstract][Full Text] [Related]
39. The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant. Kimura M; Seki T; Ozawa H; Ishihara T; Komatsu M; Tajiri S; Yanagi H; Nishina M; Noh JY; Fukagawa M; Takagi A Endocr J; 2013; 60(3):383-8. PubMed ID: 23154533 [TBL] [Abstract][Full Text] [Related]
40. Graves' Thyrotoxicosis Following SARS-CoV-2 Infection. Harris A; Al Mushref M AACE Clin Case Rep; 2021; 7(1):14-16. PubMed ID: 33521256 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]